Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug 15:305:1-11.
doi: 10.1016/j.taap.2016.05.014. Epub 2016 May 19.

Mustard vesicant-induced lung injury: Advances in therapy

Barry Weinberger  1 , Rama Malaviya  2 , Vasanthi R Sunil  2 , Alessandro Venosa  2 , Diane E Heck  3 , Jeffrey D Laskin  4 , Debra L Laskin  2
Affiliations
Review

Mustard vesicant-induced lung injury: Advances in therapy

Barry Weinberger et al. Toxicol Appl Pharmacol. .

Abstract

Most mortality and morbidity following exposure to vesicants such as sulfur mustard is due to pulmonary toxicity. Acute injury is characterized by epithelial detachment and necrosis in the pharynx, trachea and bronchioles, while long-term consequences include fibrosis and, in some instances, cancer. Current therapies to treat mustard poisoning are primarily palliative and do not target underlying pathophysiologic mechanisms. New knowledge about vesicant-induced pulmonary disease pathogenesis has led to the identification of potentially efficacious strategies to reduce injury by targeting inflammatory cells and mediators including reactive oxygen and nitrogen species, proteases and proinflammatory/cytotoxic cytokines. Therapeutics under investigation include corticosteroids, N-acetyl cysteine, which has both mucolytic and antioxidant properties, inducible nitric oxide synthase inhibitors, liposomes containing superoxide dismutase, catalase, and/or tocopherols, protease inhibitors, and cytokine antagonists such as anti-tumor necrosis factor (TNF)-α antibody and pentoxifylline. Antifibrotic and fibrinolytic treatments may also prove beneficial in ameliorating airway obstruction and lung remodeling. More speculative approaches include inhibitors of transient receptor potential channels, which regulate pulmonary epithelial cell membrane permeability, non-coding RNAs and mesenchymal stem cells. As mustards represent high priority chemical threat agents, identification of effective therapeutics for mitigating toxicity is highly significant.

Keywords: Fibrosis; Inflammatory mediators; Lung injury; Mustard gas; Therapeutic approaches; Vesicant.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Example of lung pathology from an individual exposed to mustard gas
In response to battlefield use of SM, a short report (“An Atlas of Gas Poisoning”, Medical Research Committee, British Expeditionary Forces, 1918), consisting of drawn-to-life images of individuals exposed to chemical warfare gasses and resultant lung pathology, was issued to familiarize Officers with key features of chemical warfare gas injuries of the lung. In cooperation with the American Red Cross Society, this report was made available to the American Army Medical Service. The figure is a reproduction of ‘plate no. IX’ showing ulceration of the trachea post mustard gas exposure. The original description of the pathology is described below:

“The characteristic feature is the sloughing of the tracheal mucous membrane. The reddening of the base of the tongue and of the pharynx, with a sharp delimitation where the oesophagus has refused ingress to the toxic vapor, is seen also with chlorine and other irritant gasses. But the pharyngeal inflammation with mustard gas may proceed further to a local ulceration that will cause dysphagia for many days.”

“The mucous membrane of the trachea and bronchi is affected by the di-chlor-ethyl-sulphide in much the same way as the skin. It reacts with an intense inflammation, and death of the surface layers soon results. The mass of necrotic tissue, exuded fibrin, and pus cells may forms a yellowish-grey slough in which all manner of organisms flourish. Subsequently this false membrane comes away in patches or in entire casts from the raw surface of the bronchial wall.”

“Meantime the infected debris and secretions tend to accumulate in the bronchial ramifications at the bases of the lungs, and infection may spread from them into the lung tissues and alveoli. Septic broncho-pneumonia, localised abscesses, superficial pleurisy, and even empyema or pyropneumonthorax then develop and cause death.”

“The drawing is of a trachea at the twelfth day after gassing. The base of the tongue and the pharynx show characteristic inflammation. Yellow necrotic sloughs lie on the larynx and at the bifurcation of the trachea. Between these the trachea is red and glistening, because it is now completely denuded of both mucous membrane and of slough. The dotted line points to a little group of ulcers on the posterior wall from which bleeding has occurred. The trachea and bronchi contained an abundance of this yellow pus.”

Figure 2
Figure 2. Pathology of human lung following exposure to mustard gas
Reproduction of ‘plate no. X’ in “An Atlas of Gas Poisoning” showing a section of human lung 40 h post mustard gas exposure. The original description of the pathology is described below:

“The bronchiole is filled with fibrin and pus cells, and its lining epithelium has been completely destroyed. The inflammation has caused a characteristic ring of haemorrhage in the tissues around the bronchial tube, and infection is beginning to appear in the alveoli nearest to these inflamed tissues. But there is no generalized pulmonary oedema and no disruptive emphysema.”

“Di-chlor-ethyl-sulphide [SM] may cause some catarrhal desquamation of the pulmonary endothelial cells, but it rarely excites an outpouring of oedema fluid from the pulmonary vessels. The pathological changes in the bronchioles and in the alveoli are therefore in the sharpest contrast with those caused by phosgene. As infection spreads into the lung tissues, patches of septic bronchopneumonia and small absesses develop, and these often excite an inflammatory oedema around them.”

“If the patient lives, his bronchial mucous membrane is slowly regenerated; and during this time he is naturally subject to reflex spasms of coughing or even protracted bronchitis.”

See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aasted A, Darre E, Wulf HC. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann. Plast. Surg. 1987;19:330–333. - PubMed
    1. Abbott-Banner K, Poll C, Verkuyl JM. Targeting TRP channels in airway disorders. Curr. Top. Med. Chem. 2013;13:310–321. - PubMed
    1. Adelipour M, Imani Fooladi AA, Yazdani S, Vahedi E, Ghanei M, Nourani MR. Smad molecules expression pattern in human bronchial airway induced by sulfur mustard. Iran. J. Allergy Asthma Immunol. 2011;10:147–154. - PubMed
    1. Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004;287:L1160–1164. - PubMed
    1. Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell. Rev. 2015;11:150–160. - PubMed

MeSH terms